Tiziana Life Sciences Ltd

TLSA chart

Tiziana Life Sciences Ltd news

• Tiziana Life Sciences Highlights INFORM-MS Phase 2a Results in KOL Call Update

  TipRanks · Nov 9, 3:48 PM EST

• Tiziana’s nasal foralumab reduces microglial activation in progressive MS trial

  proactiveinvestors.com · Nov 9, 2:46 PM EST

• TLSA: SEC Form 6-K filed by Tiziana Life Sciences Ltd.

  Quantisnow · Nov 9, 1:43 PM EST

• Tiziana KOL Call Highlights Consistency Between Positive Phase 2a INFORM-MS Topline Results and Longer-Term Clinical Benefits Observed in Expanded Access Program for Patients with Non-Active Secondary Progressive Multiple Sclerosis Treated with Intranasal Foralumab

  Yahoo Finance · Nov 9, 1:30 PM EST

• Small cap wrap: Montero Mining, Tiziana Life Sciences, BioVie, Ocean Power Technologies...

  Proactive financial news · Nov 9, 10:30 AM EST

• Tiziana Life Sciences to advance foralumab partnering talks at BIO-Europe 2026

  proactiveinvestors.com · Nov 9, 9:54 AM EST

• Tiziana Life Sciences Presents Foralumab Program at BIO-Europe 2026

  TipRanks · Nov 9, 7:33 AM EST

• MS trial results will headline Tiziana Life Sciences (TLSA)'s November 9 webcast at noon ET.

  Stock Titan · Nov 9, 7:21 AM EST

• Tiziana Life Sciences to Present at BIO-Europe 2026 and Host KOL Webcast

  Yahoo Finance · Nov 9, 7:00 AM EST

• symbol__ Stock Quote Price and Forecast

  CNN · Nov 9, 2:03 AM EST

• Tiziana Life Sciences Ltd Stock Price Prediction: Today, Tomorrow, Next Week (TLSA)

  Traders Union · Nov 7, 9:07 PM EST

• Tiziana Life Sciences Ltd (TLSA) stock price, news, quote and history

  Yahoo Finance Singapore · Nov 6, 8:31 AM EST

Tiziana Life Sciences Ltd key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-11-09
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-11-09
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-11-05
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-11-02
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-21
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-16
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-16
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-30
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-28
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-21
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-17
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-24

About Tiziana Life Sciences Ltd

Ticker

TLSA (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

London, England, United Kingdom

Incorporated in

Bermuda

Fiscal year end

December 31

SEC CIK

1723069

Former names

Tiziana Life Sciences plc

Frequently asked questions